CORDIS · CarrerasPathfinders

Enabling the next generation in search of blood cancer cures

Code: CarrerasPathfinders
Programme: HORIZON
Call: HORIZON-MSCA-2022-COFUND-01-01
Status: SIGNED
Period: 2024-09-01 – 2029-08-31

EU contribution (whole consortium)1 881 600 €

Official data · CORDIS · synced 2026-10-18 03:29 · official record

Participants

Organisations	Role	Country	Grant
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS	coordinator	ES	1 881 600 €
Specialized Hospital for Active Treatment of Hematological Diseases	associated partner	BG
FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE	associated partner	PT
International Society for Experimental Hematology	associated partner	US
MESOESTETIC PHARMA GROUP S.L.	associated partner	ES
Fundació Internacional Josep Carreras	associated partner	ES
ONECHAIN IMMUNOTHERAPEUTICS S.L.	associated partner	ES
ASOCIACION INNOLIFE SPAIN	associated partner	ES
UNIVERSITY OF SHARJAH	associated partner	AE
Asociación Española Contra el Cáncer	associated partner	ES
NOVOGENE UK COMPANY LIMITED	associated partner	UK
FUNDACION CIENTIFICA DE LA ASOCIACIÓN ESPANOLA CONTRA EL CANCER	associated partner	ES
BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA	associated partner	SK
Gavin Lucas	associated partner	ES
QUIMATRYX SL	associated partner	ES
FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR)	associated partner	CH
SCIENSEED SL	associated partner	ES
EUROPEAN HEMATOLOGY ASSOCIATION	associated partner	NL
APPLIED NANOPARTICLES SL	associated partner	ES
FUNDACIO INSTITUCIO DELS CENTRES DE RECERCA DE CATALUNYA	associated partner	ES
MLL MUNCHNER LEUKAMIELABOR GMBH	associated partner	DE
ONKOLOSKI INSTITUT LJUBLJANA	associated partner	SI
ANAXOMICS BIOTECH SL	associated partner	ES
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	associated partner	US
INSTITUTUL NATIONAL DE CERCETARE - DEZVOLTARE IN DOMENIUL PATOLOGIEI SI STIINTELOR BIOMEDICALE VICTOR BABES RA	associated partner	RO
BIOCAT LA FUNDACIO BIOREGIO DE CATALUNYA	associated partner	ES
APPLIED RESEARCH USING OMIC SCIENCES SL	associated partner	ES
NEW YORK UNIVERSITY	associated partner	US
USTAV MOLEKULARNI GENETIKY AV CR V.V.I.	associated partner	CZ
FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)	associated partner	ES
FUNDACION PARA EL CONOCIMIENTO MADRIMASD	associated partner	ES
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION	associated partner	ES
HUMANITAS MIRASOLE SPA	associated partner	IT
UNIVERSITY OF CYPRUS	associated partner	CY
SEMMELWEIS EGYETEM	associated partner	HU
UNIVERSITA DEGLI STUDI DI TORINO	associated partner	IT
CONSORCIO PARA LA CONSTRUCCION EQUIPAMIENTO Y EXPLOTACION DEL LABORATORIO DE LUZ SINCROTRON	associated partner	ES
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	associated partner	CH
UNIVERSITETET I OSLO	associated partner	NO
UNIVERSITY OF NEWCASTLE UPON TYNE	associated partner	UK
UNIVERSITE LIBRE DE BRUXELLES	associated partner	BE
UNIVERSITAT DE BARCELONA	associated partner	ES
UNIVERSITAT AUTONOMA DE BARCELONA	associated partner	ES
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG	associated partner	DE
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV	associated partner	DE
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	associated partner	ES
CHARITE - UNIVERSITAETSMEDIZIN BERLIN	associated partner	DE

Description

The CarrerasPathfinder program is new a world-wide unique doctoral program that covers the entire spectrum of research and innovation in blood cancers from understanding disease biology to the implementation of novel processes in the clinical practice. The program will fund 14 excellent Doctoral Candidates (DCs) for a period of 48 months. DCs will perform collaborative PhD projects involving associated partners from different sectors, countries, and disciplines through secondments. DCs will improve their research capacity and transferable skills through high-quality supervision arrangements and a tailored training program.The program has been designed and will be hosted by the Josep Carreras Leukaemia Research Institute (IJC) which is the first European non-profit institute exclusively devoted to blood cancers. By answering the European needs for human resources, it is fully aligned with the 13 recommendations of the EU Cancer Board’s Draft Mission and the Europe’s Beating Cancer Plan (2021). The CarrerasPathfinder program has a strong triple-I dimension of internationality, inter-sectorality and interdisciplinarity in training, networking, co-supervision and research. Its specific objectives are:•To develop an excellent doctoral program in blood cancer research conceived as a pilot for a permanent international doctoral program•To equip DCs with a unique skill set boosting effectiveness and innovation capacity. •To promote DCs’ career development and increase their employability in different sectors.•To establish the IJC as a European reference for research and training in blood cancers.•To provide Europe with a new generation of researchers able to address unmet needs and societal challenges of blood cancers.•To contribute to structuring the European research area by collaborating and synergizing with other European key opinion leaders.

Official data · CORDIS · synced 2026-10-18 03:29 · official record · Licence: © European Union, CC BY 4.0 (Commission reuse policy).